ArticleJournal of geriatric oncology2022

Phase Ib trial of lenalidomide as post-remission therapy for older adults with acute myeloid leukemia: Safety and longitudinal assessment of geriatric functional domains.

Justin D Woods et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.